Inventor · disambiguated record
Huaqiang Eric Xu
Also filed as: XU HUAQIANG · XU HUAQIANG E · XU HUAQIANG ERIC
14 granted patents·10 pending applications·141 citations·filing 2000–2021
89Inventor score
Files withZHEJIANG PALO ALTO PHARMACEUTICALS INC6XU HUAQIANG ERIC4SMITHKLINE BEECHAM CORP3VAN ANDEL RES INST3SHANGHAI INST MATERIA MEDICA CAS2
Top patents by PatentIndex Score
24 records- 0193US6710063B1Activators of PPAR deltaSMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 23, 2004·69 cites·20 claims
- 0292US6723740B2Activator of PPAR deltaSMITHKLINE BEECHAM CORP·Filed 2003·Granted Apr 20, 2004·55 cites·1 claims
- 0381US10668090B2Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2018·Granted Jun 2, 2020·2 cites·4 claims
- 0480US8563513B2Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of useXU HUAQIANG ERIC·Filed 2010·Granted Oct 22, 2013·4 cites·31 claims
- 0574US12240841B2FXR small molecule agonist and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Mar 4, 2025·1 cites·15 claims
- 0670US8173670B2Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoidsXU HUAQIANG ERIC·Filed 2010·Granted May 8, 2012·3 cites·9 claims
- 0763US7238778B2Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing sameSMITHKLINE BEECHAM CORP·Filed 2002·Granted Jul 3, 2007·7 cites·4 claims
- 0858US10913765B2Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate compound, and application thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Feb 9, 2021·0 cites·3 claims
- 0958US10899787B2Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific delivery and useZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Jan 26, 2021·0 cites·4 claims
- 1057US10913766B2Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Feb 9, 2021·0 cites·5 claims
- 1149US2023357244A1Fxr small-molecule agonist, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1249US2023312584A1Salt of nucleoside analog, and crystal form, pharmaceutical composition and use thereofVIGONVITA LIFE SCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1347US11008361B2Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 1446US2015376252A1Norrin Mutant Polypeptides, Methods of Making and Uses ThereofVAN ANDEL RES INST·Filed 2014·Application pending·0 cites
- 1546US2007111265A1Ligands for mineralocorticoid receptor (MR) and methods for screening for or designing MR ligandsVAN ANDEL RES INST·Filed 2006·Application pending·0 cites
- 1645US9975918B2Highly potent glucocorticoidsVAN ANDEL RES INSTITUTE·Filed 2014·Granted May 22, 2018·0 cites·6 claims
- 1744US10954265B2Structures and mechanism for the design of highly potent glucocorticoidsVAN ANDEL RES INSTITUTE·Filed 2017·Granted Mar 23, 2021·0 cites·10 claims
- 1844US2007026059A1Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1)XU HUAQIANG E·Filed 2006·Application pending·0 cites
- 1944US2009215686A1Nk1-based polypeptides and related methodsXU HUAQIANG ERIC·Filed 2008·Application pending·0 cites
- 2041US2013045952A1ABA Receptor Agonists for Increased Plant Stress ResistanceVAN ANDEL RES INST·Filed 2012·Application pending·0 cites
- 2140US10640515B2Hepatitis C virus inhibitor and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·0 cites·7 claims
- 2234US2004137518A1CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAMEFiled 2002·Application pending·0 cites
- 2332US2011237497A1Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of useXU HUAQIANG ERIC·Filed 2010·Application pending·0 cites
- 2423US2012045459A1Methods for Treating Autophagy-Related DisordersMACKEIGAN JEFFREY PAUL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huaqiang Eric Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →